Skip to main content
Download PDF

Study of the protective effect on intestinal mucosa of the hydrosoluble fiber Plantago ovata husk

BMC Complementary and Alternative Medicine volume 15, Article number: 298 (2015) Cite this article

Abstract

Background

Several studies have indicated that dietary fiber may have a protective effect on gastrointestinal mucosa. The aim of this study was to evaluate the protective action of the soluble fiber Plantago ovata husk against intestinal damage.

Methods

To evaluate the anti-ulcerogenic effect on duodenal mucosa of the soluble fiber Plantago ovata husk, low-dose acetylsalicylic acid (10 mg/kg) was given orally to animals once daily for 14 or 28 days with and without Plantago ovata husk (100 mg/kg). 24 h after final dosing duodenal samples were removed for anatomopathological evaluation. Villi were examined by both light and scanning electron microscopy.

Results

Acetylsalicylic acid induced severe lesions in duodenal mucosa of rabbits, including erosions, epithelium disorganization, and cell vacuolization, increasing as well the amount of mononuclear and caliciform cells. Damage was much more severe in animals treated for 28 days. In groups receiving Plantago ovata husk, a significant attenuation of acetylsalicylic acid-induced lesions was already observed in group treated for 14 days, becoming more evident in those treated for 28 days, all of them with duodenal cytoarchitecture normal and similar to control animals.

Conclusions

These findings suggest that Plantago ovata husk may protect intestinal mucosa probably by limiting acetylsalicylic acid penetration into epithelial cells, although further studies are needed to confirm the same effect in other experimental models of induced mucosal damage and to elucidate the mechanisms of fiber protection.

Peer Review reports

Background

Dietary fiber can be defined as an edible component of all plants which is resistant to digestion and absorption in the human gut but available for total or partial fermentation in the large intestine [1–3]. Health benefits of high dietary fiber intake have been documented for centuries, although it is not until recent decades that fiber supplements have gained increasing attention [4–7].

According to their physico-chemical properties, dietary fibers are classified as hydrosoluble, soluble or viscous (pectin, gum, mucilage, Plantago ovata husk) and water-insoluble, insoluble or non-viscous (cellulose, hemicellulose, lignin) [8]. Regarding Plantago ovata, it is a plant which has been used traditionally in medicine because of its high content of fiber. The outest coating of Plantago ovata seeds (also termed as Plantago ovata husk or psyllium husk), obtained by milling of these seeds, is an excellent source of soluble fiber, and has become one of the most widely consumed fiber supplements, as it is well tolerated, relatively inexpensive and available in several galenic forms. Many beneficial health-related biological properties have been attributed to Plantago ovata husk. Among them, this fiber has been shown to prevent constipation [9, 10], diarrhea [11], Crohn’s disease [12], obesity [13], hypercholesterolemia [14–17], diabetes [17, 18] and atherosclerosis [19].

Duodenal ulcer is one of the most common gastrointestinal disorders all over the world, with an incidence of 0.04 % in the general population [20, 21]. It is developed when there is an imbalance between injurious factors (Helicobacter pylori, HCl, pepsins, non-steroidal anti-inflammatory drugs (NSAID), bile acids, ischemia, hypoxia, smoking or alcohol) and protective factors (bicarbonate, mucus layer, mucosal blood flow, growth factors and prostaglandins) at the luminal surface of the epithelium [22], being Helicobacter pylori and the widespread use of conventional NSAID such as acetylsalicylic acid the leading causes of this pathology [23, 24].

Several studies have suggested that a high fiber intake, especially soluble fibers, would have a mucosa-protective action, reducing the risk or promoting a faster healing of duodenal ulcers [25, 26]. Satoh et al. [27] have shown that diet supplementation with soluble fibers protects the small intestine against NSAID-induced damage in cats, but this study has been carried out over a short period of time (3 days). Thus, the aim of this study was to evaluate the protective action of the soluble fiber Plantago ovata husk against intestinal damage. To achieve this, we have used a well-known ulcerogenic agent (acetylsalicylic acid) that was orally administered for different periods of time (14 and 28 days) to rabbits.

Methods

Animals

Thirty healthy male New Zealand white rabbits (Granja San Bernardo, Tulebras, Navarra, Spain), weighing between 2.64 and 3.40 kg were used in this study. They were maintained in a restricted access room in the Animal Care Facility at the University of León (Spain), in metal cages which allowed the isolation of faeces in a lower container to avoid coprophagia. The environmental conditions were: humidity (55 ± 10 %), temperature (19 ± 2 °C), and a 12 h light-2 h dark cycle. Rabbits were maintained under these conditions for 7 days before the experiments. Standard laboratory chow and tap water were provided ad libitum. All experimental protocols were approved in advance by the Animal Care Committee at the University of León, and they were performed in accordance with the guidelines of the European and Spanish legislation.

Treatments

The animals were randomly divided in five groups of six rabbits each. Groups I to IV were daily treated with acetylsalicylic acid (Sigma-Aldrich, St Louis, MO) by the oral route at a dose of 10 mg/kg. Groups I and II received acetylsalicylic acid for 14 days, whereas in Groups III and IV the same drug was administered for 28 days. Moreover, Plantago ovata husk (Plantaben®, Rottapharm SL, Barcelona, Spain) was also administered orally to Groups II and IV at a dose of 100 mg/kg, equivalent to a human dose. Finally, Group V was used as control and received only water. Animals were weighed every week in order to adjust doses of acetylsalicylic acid and fiber. Acetylsalicylic acid and Plantago ovata husk were administered by gastric intubation once daily every morning at the same hour. Acetylsalicylic acid was always administered dispersed in 5 ml water, followed by another 5 ml to wash the cannula. In Groups II and IV the fiber was given first, dispersed in 20 ml water, and followed by another 20 ml to remove any rest of fiber, administering then acetylsalicylic acid using the same cannula. In any of the treatments a total volume of 50 ml was used for administration and cannula cleaning.

Histological study

Twenty-four hours after the last treatment, rabbits were sacrificed by an intravenous sodium pentobarbital overdose (200 mg/kg) (Roig Farma, Barcelona, Spain). Proximal duodenum was removed, opened with a longitudinal incision, and gently washed with saline. Samples of 2 cm each were removed from the proximal region of duodenum to perform the histological evaluation. Tissue samples were investigated by both light and scanning electron microscopy. For light microscopic studies, duodenum specimens were fixed in Bouin fluid for 48 h, dehydrated in an ascending series of ethyl alcohol, and embedded in paraffin. Approximately 5-μm-thick sections were stained with hematoxylin and eosin (H & E)/alcian blue/periodic acid Schiff for general morphology. Sections were photographed using a Nikon Eclipse microscope (Japan). For examination under scanning electron microscope, duodenum sections were fixed using 2.5 % glutaraldehyde in phosphate buffer saline (PBS) (pH 7.4). Subsequently, sample tissues were then postfixed for 2 h in 1 % osmium tetroxide in 0.05 M cacodylate buffer (pH 7.4). After fixing, tissue sections were dehydrated through a 50, 70, 90 and 100° series of acetone solutions, dried with liquid CO2 under pressure with critical point dryer, and covered with gold particles as preparation for examining by scanning electron microscope (JEOL JSM-6480 LV, Tokyo, Japan) in order to observe the ultrastructure of duodenal cells. A minimum of 10 images were photodocumented and analyzed from each animal at both light and scanning electron microscopic levels, and histological assessments were always made being unaware of the corresponding experimental group.

Statistical analysis

All data are expressed as mean ± standard deviation (SD). Group comparisons were performed by using an analysis of variance (ANOVA) followed by a Student’s t-test. A P value of ≤ 0.05 was considered significant. Statistical analyses were performed with GraphPad Prism v. 4.0 (GraphPad Software, San Diego, CA).

Results

Control group samples showed a normal duodenal mucosa. Enterocyte layer was intact and firmly joined to underlying lamina propria, and a uniform glycocalyx was also found. Cells had a regular pattern, with spherical nuclei uniformly arranged in the basal cytoplasm (Fig. 1(a)). Compared with control animals, in rabbits treated with acetylsalicylic acid for 14 days small discontinuities were observed in glycocalix, and epithelium was disorganized and slightly vacuolized. In some samples, losses of nuclei and cell contents towards the lumen were also observed (Fig. 1(b)).

Fig. 1
figure 1

Light micrographs of rabbit duodenal mucosa showing the effect of Plantago ovata husk on aspirin-induced lesions. a and b Normal mucosa in control animals. d After 14-day aspirin treatment, epithelium disorganization and vacuolization was observed, with losses of content cell and nuclei (arrows), (e) also increasing the presence of caliciform cells in epithelium. In rabbits treated with fiber and aspirin for 14 days (c and f) Plantago ovata protected against aspirin-induced lesions, maintaining enterocyte integrity and keeping the number of caliciform cells close to control values (arrows). g After 28-day aspirin administration, villi are flattened and showed important erosions with 28-day treatment, and (h) the number of caliciform cells increased significantly, probably to augment mucin secretion. i Pretreatment with Plantago ovata husk for 28 days protected against aspirin-induced lesions, maintaining as well epithelium integrity. Hematoxyline and eosin staining: a, c and d, 40X, scale bar 20 μm; g, 4X, scale bar 100 μm. Periodic acid-Schiff (PAS) staining: b and f, 20X, scale bar 40 μm; i, 40X, scale bar 20 μm; h 10X, scale bar 50 μm. Alcian blue-PAS staining: e 40X, scale bar 20 μm

Full size image

After chronic 28-day acetylsalicylic acid administration, numerous alterations in duodenal mucosa were found (Fig. 1(c)). Greater epithelium disorganization and vacuolization were noted, with more pronounced gaps. Nuclei tend to be oval-shaped and located at different heights in the medial portion instead in the basal one, due to the occurrence of blebs near the basal membrane. Moreover, villi were disorganized and flattened, with large and severe discontinuities in the apical area (Fig. 1(d)). Nevertheless, epithelium obtained from rabbits receiving acetylsalicylic acid and Plantago ovata husk (Figs. 1(e) and (f)) showed similar features to control samples: it was well preserved, no vacuolization was seen, and cells were firmly joined to basal lamina. Only nuclei tended to be oval-shaped and located in the basomedial region of cells.

Table 1 includes the percentage of caliciform cells, infiltrated mononuclear cells as well as the enterocytes characteristics determined in the different groups of rabbits.

Table 1 Percentage of caliciform cells, infiltrated mononuclear cells and enterocytes characteristics determined in the different groups of rabbits studied
Full size table

As can be seen, in rabbits treated with acetylsalicylic acid a significant increase in the percentage of caliciform cells was observed in duodenal epithelium when compared to control group, being 18.7 % after 14-day treatment and 23.5 % following 28-day administration, while in control animals the value was 13.5 % (P < 0.05). These values were reduced and back to control levels in animals treated with fiber: 11.8 % and 13.25 % with 14-day or 28-day treatment, respectively (significant differences compared with acetylsalicylic acid treatments, P < 0.05).

Mononuclear infiltrated cells in villi also augmented with increasing times of exposure to acetylsalicylic acid, rising significantly its percentage from 1.8 % in control group to 19.3 % and 23.8 % in animals treated with this drug for 14 and 28 days, respectively (P < 0.05). Again, infiltrated cells diminished to 6.7 % (14 day-treatment) and 8 % (28-day treatment) in rabbits receiving Plantago ovata husk concomitantly. Although these values were close to those obtained in control animals, significant differences were observed when comparing to control group and acetylsalicylic acid groups (P < 0.05).

Finally, scanning electron microscopy revealed a normal topography of duodenal enterocytes in control group (Fig. 2(a)). In those animals that underwent treatment with acetylsalicylic acid, three types of enterocytes were observed: cells with no alterations, slightly affected enterocytes (SAE) and those strongly affected (STE). In SAE, a clear separation among cells was observed, although intercellular spaces became wider in comparison with control group, and microvilli appeared to be fused. When STE are considered, cells could be differentiated only if they were surrounded by healthy or SAE enterocytes, but if several STE were adjacent, they appeared fused among themselves. In animals treated with acetylsalicylic acid for 14 days (Fig. 2(b)), these three types of enterocytes were uniformly distributed in villi, whereas in those receiving the same treatment for 28 days (Fig. 2(d) and (e)), STE were more frequent, with duodenal microvilli almost completely fused as a continuous smooth surface. In contrast, microvilli were well defined in specimens obtained from those animals treated with Plantago ovata husk and acetylsalicylic acid: they were similar to those observed in the control group as well, without apparent signs of damage (Fig. 2(c) and (f)).

Fig. 2
figure 2

Scanning electron micrographs of rabbit duodenal mucosa, showing ultraestructural changes in enterocytes. a Villi of normal duodenal mucosa (scale bar = 1 μm, original magnification 10000x). b Villi of animals treated with acetylsalicylic acid for 14 days, with microvilli fused (scale bar = 1 μm, original magnification 10000x). c Villi of rabbits treated with Plantago ovata husk + acetylsalicylic acid for 14 days, with clearly defined limits in enterocytes (scale bar = 1 μm, original magnification 10000x). d Villi of animals treated with acetylsalicylic acid for 28 days, with microvilli aggregated (scale bar = 1 μm, original magnification 10000x). e Villi of animals treated with acetylsalicylic acid for 28 days, with slightly affected enterocytes (SAE) and strongly affected cells (STE). When several strongly affected enterocytes were adjacent, it is not possible to delimitate cells (scale bar = 5 μm, original magnification 2000x). f Villi of rabbits treated with Plantago ovata husk + acetylsalicylic acid for 28 days. Cell limits are well defined and exhibited no changes (scale bar = 5 μm, original magnification 5000x)

Full size image

As we have mentioned above, Table 1 includes the characteristics obtained for enterocytes: area, perimeter and shape (number of faces). The area of the enterocytes was significantly lower in the groups of animals treated with acetylsalicylic acid and fiber for 14 days (30.2 μm2) or 28 days (39.1 μm2). Regarding the perimeter, the lowest value was found in the group of animals treated with acetylsalicylic acid and fiber for 28 days (25.7 μm). The shape of the enterocytes was evaluated taking into account the number of faces of the cell. The number of enterocytes with 5 faces was similar in all groups of animals and represented at least the 50 % of the cells. The highest percentage of cells with 4 faces was observed in the control group (28 %) and with 6 faces in the group of animals treated with acetylsalicylic acid and fiber for 28 days (34 %).

Discussion and conclusions

Animal models of any human disease are used to mimic human conditions as much as possible in order not only to understand that disease but also to evaluate potential treatments. Among the different models of experimentally induced gastrointestinal lesions, the NSAID model is frequently used [28]. The present study was designed to address whether the hydrosoluble fiber Plantago ovata husk would prevent the development of duodenal lesions induced when both fiber and acetylsalicylic acid have been chronically administered.

Our study shows that severe duodenal damage may be induced by low-dose acetylsalicylic acid administration, resulting in the loss of surface epithelium and massive mononuclear infiltration. Moreover, injuries become more severe with increasing time of exposure to this drug: villi were more shortened, enterocytes were more disorganized, and structural alterations in duodenal mucosa (such as villi erosions, epithelium disorganization or blebs occurrence) were much more severe after 28-day treatment, rising significantly the amount of caliciform and infiltrated mononuclear cells as well. Severe lesions have also been reported in small intestine of rats with short-term administration of acetylsalicylic acid [29] and indomethacin [27, 30], and other authors reported an increase of mononuclear cell infiltration in gastrointestinal mucosa after having administered NSAID [31–33]. Lesions described in our study are also in accordance with the results reported by other authors in human patients, in which a higher risk of duodenal or upper gastrointestinal bleeding after chronic administration of low-dose acetylsalicylic acid was described [34, 35].

Previous studies carried out in laboratory animals and patients pointed out that several mechanisms could contribute to acetylsalicylic acid damage on the small intestine mucosa. On the one hand, the drug has a direct irritant action on the intestinal epithelium, which is considered a determinant factor in the initiation of damage. As consequence of the breach in the intestinal barrier, the release of different mediators involved in the inflammatory response would attract neutrophils into the epithelium [36, 37]. The increase in the amount of infiltrated mononuclear cells (and subsequent mucosa inflammation) in our study would confirm this hypothesis. Intestinal mucin secretion, which plays a key role in gastrointestinal protection, would also be inhibited by acetylsalicylic acid [38]. The lack of mucus on the mucosa allows luminal acid to penetrate and damage the basal lamina, retarding re-epithelization process [39]. Our results are also in accordance with this latter hypothesis, as the amount of caliciform cells is significantly augmented in animals receiving acetylsalicylic acid, probably to compensate for lower mucus secretion due to this NSAID.

Taking into account the results of this study, it is evident that long-term administration of Plantago ovata husk together with acetylsalicylic acid ameliorates the morphological signs of duodenal mucosal damage induced by this NSAID. This fiber tends to maintain the cytoarchitecture of the duodenal mucosa in the normal arrangement of its components, blocking thus the injurious effect of acetylsalicylic acid at this level, with well-preserved enterocytes and villi, basomedial nuclei, cytoplasm without apparent alterations, and with an amount of caliciform and mononuclear cells close to those observed in control samples. Mucosal damage was clearly minimized by Plantago ovata husk, and we think that this fiber would develop not only a protective action against deleterious effects of acetylsalicylic acid but also a restorative one, favoring the epithelial turnover and regeneration. In this sense, fiber was able to stimulate proliferation in the gastric glands directly [40], and fractions of Plantago ovata strongly stimulated the proliferation of keratinocytes [41].

We have not found any other study in which the protective effect of Plantago ovata husk against acute or chronic damage caused by NSAID in the small intestine has been described. In large bowel, Plantago ovata resulted as effective as mesalamine to maintain remission in ulcerative colitis [12] and preserved intestinal epithelium in a colitis experimental model carried out in HLA-B27 rats, with an increase in mucin secretion, a reduction of oedema and a lesser infiltration of mononuclear cells [42]. Regarding small intestine, food supplementation with soluble dietary fibers (pectin, guar gum or polydextrose) prevented the formation of duodenal ulcers induced by indomethacin when treatment was administered for 3 days to cats [27].

Several mechanisms can be involved in the protective effects of Plantago ovata husk observed in the intestinal epithelium. Due to the ability of this fiber to fix organic and inorganic substances, their absorption by the intestinal epithelium is delayed, reduced or even avoided, protecting this epithelium from a potential damage [43, 44]. So, fiber can retain acetylsalicylic acid, reducing the lessions observed in the epithelium. On the other hand, Plantago ovata husk is a highly hydrosoluble fiber, and makes markedly viscous solutions, increasing the thickness of the intestinal diffusion barrier. This effect would help to maintain the morphofunctional integrity of intestinal epithelium by preventing or slowing acetylsalicylic acid penetration and trapping in the intestinal mucosa and, consequently, the topical action and the extensive lesions induced by this drug at this level. Moreover, viscosity is also associated with prolonged gastric emptying [45], increasing the retention of acetylsalicylic acid in stomach and, consequently, delaying the access of this drug to intestinal mucosa.

Dietary fibers may also protect duodenal mucosa by decreasing gastric acid secretion [26, 46], diminishing the load of harmful acid that could have access to duodenal mucosa. Additional mechanisms may include an anti-inflammatory action, reducing proinflammatory biomarkers such as C-reactive protein, IL-6, IL-12 or tumor necrosis factor-α [47, 48].

Taking into account the results obtained in this study, we can conclude that Plantago ovata husk, administered at the same time as acetylsalicylic acid, avoids the gastrointestinal lesions caused by this drug. This fact can be due to the solubility and viscosity of the fiber, or due to a reduction in the absorption of acetylsalicylic acid, although further studies are needed to confirm the same effect in other experimental models of induced mucosal damage and to elucidate the mechanisms of fiber protection.

References

  1. 1.

    Theander O, Åman P, Westerlund E, Graham H. Enzymatic/chemical analysis of dietary fiber. J AOAC Int. 1994;77:703–9.

    CAS  PubMed  Google Scholar 

  2. 2.

    Otles S, Ozgoz S. Health effects of dietary fiber. Acta Sci Pol Technol Aliment. 2014;13:191–202.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Turner ND, Lupton JR. Dietary fiber. Adv Nutr. 2011;2:151–2.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Sierra M, Garcia JJ, Fernández N, Diez MJ, Calle AP, Sahagún AM. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur J Clin Nutr. 2001;55:235–43.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Ramos SC, Fonseca FA, Kasmas SH, Moreira FT, Helfenstein T, Borges NC, et al. The role of soluble fiber intake in patients under highly effective lipid-lowering therapy. Nutr J. 2011;10:80–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142:1304–13.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Fissore EN, Santo Domingo C, Gerschenson LN, Giannuzzi L. A study of the effect of dietary fiber fractions obtained from artichoke (Cynara cardunculus L. var. scolymus) on the growth of intestinal bacteria associated with health. Food Funct. 2015;6:1667–74.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Mittendorfer B, Patterson BW, Klein S, Sidossis LS. VLDL triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab. 2003;284:708–15.

    Article  Google Scholar 

  9. 9.

    Bouchoucha M, Faye A, Savarieau B, Arsac M. Effect of an oral bulking agent and a rectal laxative administered alone or in combination for the treatment of constipation. Gastroenterol Clin Biol. 2004;28:438–43.

    Article  PubMed  Google Scholar 

  10. 10.

    Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–71.

    Article  PubMed  Google Scholar 

  11. 11.

    Washington N, Harris M, Mussellwhite A, Spiller RC. Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation. Am J Clin Nutr. 1998;67:317–21.

    CAS  PubMed  Google Scholar 

  12. 12.

    Chiba M, Tsuji T, Nakane K, Komatsu M. High amount of dietary fiber not harmful but favorable for Crohn disease. Perm J. 2015;19:58–61.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79:529–36.

    CAS  PubMed  Google Scholar 

  14. 14.

    Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr. 1999;70:466–73.

    CAS  PubMed  Google Scholar 

  15. 15.

    Moreyra AE, Wilson AC, Koraym A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Int Med. 2005;165:1161–6.

    CAS  Article  Google Scholar 

  16. 16.

    Romero AL, West KL, Zern T, Fernandez ML. The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. J Nutr. 2002;132:1194–8.

    CAS  PubMed  Google Scholar 

  17. 17.

    Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA, et al. Choleterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. 2000;71:472–9.

    CAS  PubMed  Google Scholar 

  18. 18.

    Cui J, Gu X, Zhang Q, Ou Y, Wang J. Production and anti-diabetic activity of soluble dietary fiber from apricot pulp by Trichoderma viride fermentation. Food Funct. 2015;6:1635–42.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Solà R, Bruckert E, Valls RM, Narejos S, Luque X, Castro-Cabezas M, et al. Soluble fiber (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial. Atherosclerosis. 2010;211:630–7.

    Article  PubMed  Google Scholar 

  20. 20.

    Ruigómez A, Johansson S, Nagy P, Martín-Pérez M, Rodríguez LA. Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events. BMC Gastroenterol. 2014;14:205.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Lassen A, Hallas J, Schaffalitzky OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993–2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945–53.

    Article  PubMed  Google Scholar 

  22. 22.

    Konturek SJ, Konturek PC, Pawlik T, Sliwowski Z, Ochmanski W, Hahn EG. Duodenal mucosal protection by bicarbonate secretion and its mechanisms. J Physiol Pharmacol. 2004;55 Suppl 2:5–17.

    PubMed  Google Scholar 

  23. 23.

    Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243–9.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29:938–46.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Rydning A, Berstad A. Fiber diet and antacids in the short-term treatment of duodenal ulcer. Scand J Gastroenterol. 1985;20:1078–82.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Aldoori WH, Giovannucci EL, Stampfer MJ, Rimm EB, Wing AL, Willett WC. Prospective study of diet and the risk of duodenal ulcer in men. Am J Epidemiol. 1997;145:42–50.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Satoh H, Hara T, Murakawa D, Takata K. Soluble dietary fiber protects against nonsteroidal anti-inflammatory drug-induced damage to the small intestine in cats. Dig Dis Sci. 2010;55:1264–71.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Lee A. Animal models of gastrointestinal ulcer disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:75–96.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Nonoyama K, Nakagawa K, Amagase K, Takeuchi K, Nakamura M, Okabe S. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin. J Gastroenterol Hepatol. 2010;25 Suppl 1:15–22.

    Article  Google Scholar 

  30. 30.

    Ettarh RR, Carr KE. Structural and morphometric analysis of murine small intestine after indomethacin administration. Scand J Gastroenterol. 1993;28:795–802.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Low J, Grabow D, Sommers C, Wallace J, Lesch M, Finkel M, et al. Cytoprotective effects of CL-959 in the rat gastric mucosa: modulation of leukocyte adhesion. Gastroenterology. 1995;109:1224–33.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Kakar S, Pardi D, Burgart L. Colonic ulcers accompanying collagenous colitis: implication of non steroidal anti-inflammatory drugs. Am J Gastroenterol. 2003;98:1834–7.

    Article  PubMed  Google Scholar 

  33. 33.

    Wallace JL, Keenan CM, Granger DN. Gastric ulceration by non steroidal anti-inflammatory drugs is a neutrophil-dependant process. Am J Physiol. 1990;259:462–7.

    Google Scholar 

  34. 34.

    Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wiholm BE, Alfredsson L, et al. Non steroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther. 1993;53:485–94.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin. 2007;23:163–73.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Soll A. Pathogenesis of non steroidal anti-inflammatory drug related upper gastrointestinal toxicity. Am J Med. 1998;105:10–6.

    Article  Google Scholar 

  37. 37.

    Morise Z, Granger D, Fuseler J, Anderson DC, Grisham MB. Indomethacin induced gastropathy in CD18, intracellular adhesion molecule 1 or P-selectin deficient mice. Gut. 1999;45:523–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Cohen MM, Clark L. Preventing acetylsalicylic acid damage to human gastric by use of prostaglandin E2. Surgery. 1983;26:116–8.

    CAS  Google Scholar 

  39. 39.

    Wallace JL, Whittle BJ. Role of mucus in the repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents. Gastroenterology. 1986;91:603–11.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Goodlad RA, Ratcliffe B, Lee CY, Wright NA. Dietary fibre and the gastrointestinal tract: differing trophic effects on muscle and mucosa of the stomach, small intestine and colon. Eur J Clin Nutr. 1995;49 Suppl 3:S178–81.

    PubMed  Google Scholar 

  41. 41.

    Deters AM, Schröder KR, Smiatek T, Hensel A. Ispaghula (Plantago ovata) seed husk polysaccharides promote proliferation of human epithelial cells (skin keratinocytes and fibroblasts) via enhanced growth factor receptors and energy production. Planta Med. 2005;71:33–9.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Rodríguez-Cabezas ME, Gálvez J, Camuesco D, Lorente MD, Concha A, Martinez-Augustin O, et al. Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin Nutr. 2003;22:463–71.

    Article  PubMed  Google Scholar 

  43. 43.

    Leng-Peschlow E. Plantago ovata seeds as dietary fiber supplement: physiological and metabolic effects in rats. Br J Nutr. 1991;66:331–49.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Wilpart M, Roberfroid M. Intestinal carcinogenesis and dietary fibers: the influence of cellulose or Fybogel chronically given after exposure to DMH. Nutr Cancer. 1987;10:39–51.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Marciani L, Gowland PA, Spiller RC, Manoj P, Moore RJ, Young P, et al. Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr. 2000;130:122–7.

    CAS  PubMed  Google Scholar 

  46. 46.

    Magri LP, Batista LM, Albino AB, Farias-Silva E, Arcanjo M, Monteiro AR. Dietary fibers prevent etanol and non steroidal anti-inflammatory drug-induced gastric mucosal damage in rats. Nutr Res. 2007;27:109–12.

    CAS  Article  Google Scholar 

  47. 47.

    Galisteo M, Morón R, Rivera L, Romero R, Anguera A, Zarzuelo A. Plantago ovata husks-supplemented diet ameliorates metabolic alterations in obese Zucker rats through activation of AMP-activated protein kinase. Comparative study with other dietary fibers. Clin Nutr. 2010;29:261–7.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Kumar A, Henderson A, Forster GM, Goodyear AW, Weir TL, Leach JE, et al. Dietary rice bran promotes resistance to Salmonella enterica serovar Typhimurium colonization in mice. BMC Microbiol. 2012;12:71–80.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

  1. Pharmacology, Department of Biomedical Sciences, Institute of Biomedicine (IBIOMED), University of Leon, Campus de Vegazana s/n, 24071, León, Spain

    Ana M. Sahagún, Juan J. García, Ángela P. Calle, María-José Diez, Nélida Fernández, Hugo O. Portilla & Matilde Sierra

  2. Department of Molecular Biology, University of Leon, Campus de Vegazana s/n, 24071, León, Spain

    José Vaquera

  3. Pharmacology, Department of Clinical Sciences, University of Las Palmas de Gran Canaria, Campus de San Cristóbal, 35016, Las Palmas de Gran Canaria, Spain

    Juan F. Loro

Authors
  1. Ana M. Sahagún
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José Vaquera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan J. García
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ángela P. Calle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. María-José Diez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nélida Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Juan F. Loro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hugo O. Portilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matilde Sierra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nélida Fernández.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MS, JV and AMS designed the study, wrote the protocol and undertook the statistical analysis and results interpretation, HOP, JJG and APC were in charge of the animals, carried out the administration of drugs and sacrificed them, MJD, NF, and JFL carried out the histological study. All authors contributed to and have approved the final manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sahagún, A.M., Vaquera, J., García, J.J. et al. Study of the protective effect on intestinal mucosa of the hydrosoluble fiber Plantago ovata husk. BMC Complement Altern Med 15, 298 (2015). https://doi.org/10.1186/s12906-015-0827-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-015-0827-9

Keywords

  • Plantago ovata husk
  • Intestinal lessions
  • Fiber
  • Anti-ulcerogenic effect
  • Rabbits

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us